VentriFlo

VentriFlo is a pioneering medical device company specializing in the development of the VentriFlo True Pulse Pump, a novel pulsatile blood pumping system. This system is designed to mimic the natural pulsatile flow of the human heart, providing superior outcomes, reducing costs, and improving safety for pediatric and adult patients who require cardiopulmonary support during surgery or in the ICU. Unlike traditional continuous flow technologies, the VentriFlo True Pulse Pump delivers complete stroke volume, natural cadence, and physiologic rest, closely replicating the human heart's function.

The company's primary clients include hospitals, surgical centers, and intensive care units that perform cardiopulmonary procedures. VentriFlo operates in the medical device market, focusing on cardiopulmonary support technologies. The business model revolves around the development and eventual commercialization of its patented pulsatile pump technology. Revenue generation will primarily come from the sale of the VentriFlo True Pulse Pump and its associated consumables, as well as potential licensing agreements.

Currently, the VentriFlo True Pulse Pump is under development and is not yet available for commercial sale. The company has received recognition and funding, including a $25,000 award in the Pediatric Device Innovation Competition, highlighting its potential impact on pediatric care.

Keywords: pulsatile blood pump, cardiopulmonary support, pediatric patients, adult patients, surgery, ICU, medical device, innovation, safety, cost reduction.